For supplement brand founders and commercial procurement managers, navigating Minimum Order Quantities (MOQs) is often the most challenging aspect of production planning. Committing to an excessively high order volume ties up critical working capital in unsold inventory and risks product expiration. Conversely, ordering in volumes that are too small inflates your per-unit Cost of Goods Sold (COGS), erasing marketing margins and leaving you vulnerable to sudden stock-outs. Mastering MOQ dynamics is essential for sustainable growth.
Why Softgel Encapsulation Has Distinct MOQs
Unlike manual capsule filling or small-scale tablet pressing, industrial rotary die softgel encapsulation is a continuous, highly automated chemical and mechanical process with strict physical prerequisites:
The thermal gelatin melting and deaeration tanks require a substantial minimum volume of raw gelatin mass (typically 100 kg to 250 kg) to achieve the necessary ribbon thickness and elasticity.
The positive displacement injection wedge and encapsulation pumps must be primed with adequate liquid fill before stable capsule formation can begin.
The startup phase generates a small amount of calibration scrap before the rotary dies achieve steady-state hermetic sealing. Running only 5,000 or 10,000 loose softgels causes an unacceptably high scrap ratio, making the unit cost prohibitively expensive.
For these technical reasons, standard commercial bulk runs for loose softgels typically begin at 100,000 units, while packaged finished goods start at 2,000 to 5,000 bottles depending on capsule size and count.
The Economics of Scale: Unit Cost vs Order Volume
In contract pharmaceutical manufacturing, fixed setup costs are distributed across total batch size:
Cleanroom preparation, machine tooling changeovers, sanitation validation, gelatin melting, and comprehensive analytical QC release testing remain relatively constant whether producing 20,000 capsules or 200,000 capsules.
Active raw materials, gelatin, excipients, and primary packaging materials scale proportionally with order size.
Consequently, increasing an order from 50,000 softgels to 200,000 softgels can reduce your per-capsule manufacturing cost by 30% to 45%, directly expanding your gross profit margin.
Managing Secondary Packaging MOQs
A frequent operational trap for brand owners is aligning bulk capsule production with secondary packaging MOQs:
While you might order 60,000 softgels (equivalent to 2,000 bottles of 30 count), packaging suppliers for custom induction-sealed bottles, printed foil labels, and embossed secondary cartons often impose their own minimum order thresholds (frequently 5,000 to 10,000 units).
Order secondary packaging materials (bottles and cartons) in larger quantities to secure volume discounts, and manufacture bulk softgels in phased production cycles. Empty printed packaging does not expire, whereas encapsulated nutrients have a defined shelf-life clock.
Cash Flow Preservation Strategies for Growing Brands
Partner with Elate Pharma to manufacture an optimal bulk batch (e.g. 100,000 softgels) to secure lower unit pricing, while arranging scheduled monthly packaging and dispatch releases to conserve warehouse space and cash flow.
Secure pre-orders and deposits from retail pharmacy accounts, clinics, or regional distributors prior to final batch completion to fund production balance payments.
Lead Time Forecasting & Inventory Management
Never wait until your warehouse inventory reaches zero before initiating a reorder. A standard production cycle requires 4 to 6 weeks:
Week 1-2: Raw material procurement, analytical identity testing, and packaging material verification.
Week 3: Gelatin mass preparation, encapsulation, and multi-stage drying.
Week 4: Automated inspection, laser sorting, and in-house laboratory batch release testing.
Week 5-6: Primary bottle filling, induction sealing, labeling, cartoning, and final dispatch.
Maintain a rolling 90-day inventory forecast and trigger reorders when your remaining warehouse stock hits 45 to 60 days of average sales velocity.
Frequently Asked Questions (FAQ)
For finished bottled products using standard in-stock formulations, we support pilot brand launches starting from 2,000 bottles.
Within the same formulation batch, you can split bulk softgels into different bottle counts (e.g., 30 count bottles and 60 count bottles) provided labeling requirements are aligned.
Standard terms involve an initial production deposit upon contract signing, with the remaining balance due upon quality release prior to dispatch.